Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00274092

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Veterans General Hospital Taichung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00144326

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • 1796 Summer Street Halifax, Nova Scotia, Canada
  • Kingston General Hospital Kingston, Ontario, Canada
  • Respiratory/ Research Lab Toronto, Ontario, Canada
  • Montreal Chest Institute of the Royal Victoria Hospital Montreal, Quebec, Canada
View all 27 locations
View Trial Details
Completed

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

NCT00239473

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Berlin, Germany
  • MEDARS GmbH Berlin, Germany
  • Boehringer Ingelheim Investigational Site Bonn, Germany
  • Boehringer Ingelheim Investigational Site Frankfurt am Main, Germany
View all 38 locations
View Trial Details
Completed

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239421

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Med. Uni.-Klinik Graz Graz, Austria
  • Boehringer Ingelheim Investigational Site Vienna, Austria
  • Klinikum Kreuzschwestern Wels Wels, Austria
  • Sint-Vincentius Ziekenhuis Antwerp, Belgium
View all 56 locations
View Trial Details
Completed

SPIRIVA in Ususal Care

NCT00274079

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Foresterhill Healthcentre Aberdeen, United Kingdom
  • Boehringer Ingelheim Investigational Site Airdrie, United Kingdom
  • Boehringer Ingelheim Investigational Site Atherstone, United Kingdom
  • Boehringer Ingelheim Investigational Site Barry, United Kingdom
View all 44 locations
View Trial Details
Completed

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

NCT00106821

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Cooper Green Hospital Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • David Geffen School of Medicine Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00274547

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
  • Southern Arizona VA Health Care System Tuscon, Arizona, United States
  • VA Long Beach Healthcare System Long Beach, California, United States
View all 26 locations
View Trial Details
Completed

Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

NCT00239460

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Attn: William C. Bailey, M.D. Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Olive View UCLA Medical Center Sylmar, California, United States
  • Rocky Mountain Center for Clinical Research Wheat Ridge, Colorado, United States
View Trial Details

Related conditions